in the hot seat

Judges named for 2022 Houston Innovation Awards

InnovationMap Staff
Oct 7, 2022, 1:35 pm
Here's who's making the call for this year's Houston Innovation Awards. Photos courtesy

Nominations are closed, applications are out, and the city of Houston is waiting to see who are the finalists for the 2022 Houston Innovation Awards. But first — who are tasked with the job of deciding the honorees for the Houston Innovation Awards Gala on November 9?

Click here to secure your tickets to the event.

A cohort of eight of the best innovation leaders in the Bayou City — representing all corners of tech and innovation, from energy and hard tech to software and startup acceleration. Introducing: The 2022 Houston Innovation Awards judges:

Carolyn Rodz, founder and CEO of Hello Alice

Carolyn Rodz, founder and CEO of Hello Alice

Photo courtesy of Hello Alice

Carolyn Rodz is a leader in Houston innovation — both as a startup founder and as a resources for startups and small businesses across the country. As CEO, she leads Hello Alice, a company Rodz founded with Elizabeth Gore, on its mission to provide support and guidance to small business owners.

Rodz is no stranger to InnovationMap's awards program. Last year, Hello Alice was a finalist in three categories and took home the win for BIPOC-owned business.

Wogbe Ofori, founder of Wrx Companies

Photo courtesy

​Wogbe Ofori is a champion of Houston innovation, startup mentor, investor, and more. He's particularly passionate about hard tech and serves as an adviser to Houston-based Nauticus Robotics and CaringBand. He also participates as a mentor across several organizations, including MassChallenge, Capital Factory, Founder Institute, and the University of Houston.

Scott Gale, executive director of Halliburton Labs

Photo courtesy

After several years in strategy at Halliburton, Scott Gale switched gears to lead Halliburton Labs, which launched in 2020. The startup incubation lab focuses on supporting early-stage companies within climatetech and the future of energy.

Ashley Danna, senior manager of regional economic development of Greater Houston Partnership

Photo courtesy

It's Ashley Danna's job at GHP to have a pulse on companies in Houston — including tech and life science businesses. Her role is focused on marketing the Houston region as a business magnet to expanding and relocating domestic businesses to foster job creation and economic growth while collaborating and strengthening relationships with external stakeholders.

Kelly McCormick, professor at the University of Houston

Photo courtesy

Kelly McCormick has spent the better part of a decade molding young, entrepreneurial minds at the University of Houston, both as a professor and as leading UH's student startup accelerator, Red Labs.

Paul Cherukuri, vice president of innovation at Rice University

Photo courtesy of Rice

Paul Cherukuri, the executive director of the Institute of Biosciences and Bioengineering, was named the inaugural vice president for innovation at Rice University in August. In his role, Cherukuri leads Rice’s technology and commercialization infrastructure to translate breakthrough discoveries into inventions for the benefit of society.

Lawson Gow, CEO of Houston Exponential

Photo courtesy of The Cannon

Lawson Gow wears many hats within the Houston innovation ecosystem. He founded The Cannon, a Houston-wide coworking company, and now oversees Houston Exponential. He also is the founder and CEO of sportstech-focused Pokatok and chief strategy officer of SportsMap SPAC.

Natalie Harms, editor of InnovationMap

Photo courtesy

Natalie Harms has been at the helm of InnovationMap — Houston's voice for Innovation — since its inception in October 2018. She oversees all editorial operations of the site and hosts its weekly podcast, the Houston Innovators Podcast.

carolyn rodzscott galekelly mccormicklawson gowwogbe oforiashley dannapaul cherukuri2022 houston innovation awardsinnovation awards 2022

Trending News

3 Houston innovators to know this week

Building Houston

 
 

California-founded biotech startup relocates to join Houston's emerging bioeconomy

San Diego-based rBIO moved to Houston to take advantage of the growing ecosystem of biomanufacturing and synthetic biology. Photo via Getty Images

Cameron Owen had an idea for a synthetic biology application, and he pitched it to a handful of postdoctoral programs. When he received the feedback that he didn't have enough research experience, he decided to launch a startup based in San Diego around his idea. He figured that he'd either get the experience he needed to re-apply, or he'd create a viable company.

After three years of research and development, Owen's path seems to have taken him down the latter of those two options, and he moved his viable company, rBIO, to Houston — a twist he didn't see coming.

“Houston was not on my radar until about a year and a half ago,” Owen says, explaining that he thought of Houston as a leading health care hub, but the coasts still had an edge when it came to what he was doing. “San Diego and the Boston area are the two big biotech and life science hubs.”

But when he visited the Bayou City in December of 2021, he says he saw first hand that something new was happening.

“Companies from California like us and the coastal areas were converging here in Houston and creating this new type of bioeconomy,” he tells InnovationMap.

Owen moved to Houston last year, but rBIO still has an academic partner in Washington University in St. Louis and a clinical research organization it's working with too, so he admits rBIO's local footprint is relatively small — but not for long.

"When we look to want to get into manufacturing, we definitely want to build something here in Houston," he says. "We’re just not to that point as a company."

In terms of the stage rBIO is in now, Owen says the company is coming out of R&D and into clinical studies. He says rBIO has plans to fundraise and is meeting with potential partners that will help his company scale and build out a facility.

With the help of its CRO partner, rBIO has two ongoing clinical projects — with a third coming next month. Owen says right now rBIO is targeting the pharmaceutical industry’s biologics sector — these are drugs our bodies make naturally, like insulin. About 12 percent of the population in the United States has diabetes, which translates to almost 40 million people. The demand for insulin is high, and rBIO has a way to create it — and at 30 percent less cost.

This is just the tip of the iceberg — the world of synthetic biology application is endless.

“Now that we can design and manipulate biology in ways we’ve never been able to before,” Owen says, "we’re really only limited by our own imagination.”

Synthetic biology is a field of science that involves programing biology to create and redesign natural elements. While it sounds like science fiction, Owen compares it to any other type of technology.

“Biology really is a type of software,” he says. “Phones and computers at their core run on 1s and 0s. In biology, it’s kind of the same thing, but instead of two letters, it’s four — A, C, T, and G.”

“The cool thing about biology is the software builds the hardware,” he continues. “You put that code in there and the biology builds in and of itself.”

Owen says the industry of synthetic biology has been rising in popularity for years, but the technology has only recently caught up.

“We’re exploring a brave new world — there’s no doubt about that,” Owen says.

BiologicsBiotechCameron OwenInsulinLife SciencePharmaceutical IndustrySynthetic BiologyWashington UniversityrBIObiomanufacturing

Trending News

3 Houston innovators to know this week